8-K ·Filed Aug 10, 2026
8-K context-dependent: Items 7.01
Actionable Insight • Neutral
No material financial or operational impact from this executive promotion. Monitor next quarterly filing for commercial execution updates and revenue trends. Recent insider selling of $3.8M over 30 days is notable but not triggered by this filing.
Latest settled — T+20d
SI ▼ -3.66% at T+20d
NEUTRAL call -3.66% · α vs SPY -2.75% · entry $20.75 → $19.99
Latest observation: T+53 -25.15% FF3 residual α
T+1d
-5.40%
call -5.40% · α -5.08%
$19.63
settled 3mo ago
T+5d
-4.00%
call -4.00% · α -3.95%
$19.92
settled 2mo ago
T+20d
-3.66%
call -3.66% · α -2.75%
$19.99
settled 7w ago
T+60d
Pending
in 7d
Price Chart
Loading chart...
Executive Summary
Shoulder Innovations promoted Jon Osborne from VP of Commercial Development to Chief Commercial Officer, effective August 6, 2026. This is a routine internal promotion with no accompanying financial data, guidance, or material operational changes — neutral for the stock.
Key Facts
- Jon Osborne promoted to Chief Commercial Officer effective August 6, 2026
- Osborne previously served as VP of Commercial Development since September 2023
- Prior experience includes VP of Commercial Marketing at Smith & Nephew and roles at ArthroCare, Tornier USA, and Team Surgical
- No financial data, guidance, or preliminary results disclosed in the filing
Financial Impact
Not specified
Risk Factors
- Executive change risk is immaterial — internal promotion with continuity
- No financial disclosure — no basis for revising forward expectations
Market Snapshot
Exchange
NYSE
Sector
Surgical & Medical Instruments & Apparatus
Analyst Consensus
92% bullish (12 analysts)
Investment Themes
Healthcare & Medical Devices
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001699350-26-000054 |
| Exhibit: ex-991pressrelease8x10x2026.htm | 0001699350-26-000054 |
| Document: 0001699350-26-000054-index-headers.html | 0001699350-26-000054 |
| Document: 0001699350-26-000054-index.html | 0001699350-26-000054 |
| Document: 0001699350-26-000054.txt | 0001699350-26-000054 |
10 reports for SI
75% Hit rate @ T+60 Went positive at some point 4 of 4 best @ T+60▲ +50.11%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 15, 2026 11d ago | Press Release | $18.09 | awaiting T+60 | — | $19.97 (+10.39%) |
Oct 8, 2026 19d ago | 8-K | $17.89 | awaiting T+60 | — | $19.97 (+11.63%) |
Aug 24, 2026 9w ago | Insider Cluster | $22.32 | awaiting T+60 | — | $19.97 (−10.53%) |
Aug 14, 2026 10w ago | EFFECT | $20.73 | awaiting T+60 | — | $19.97 (−3.67%) |
Aug 10, 2026 11w ago | 8-K | $20.75 | awaiting T+60 | — | $19.97 (−3.76%) |
Jul 29, 2026 12w ago | 144 | $23.72 $19.75 | ▲ +16.74% | ▲ +21.47% | $19.97 (+15.81%) |
Jun 29, 2026 17w ago | 8-K | $21.09 $17.61 | ▼ −16.50% | ▼ −20.89% | $19.97 (−5.31%) |
May 13, 2026 23w ago | 8-K | $15.59 $20.75 | ▲ +33.10% | ▲ +29.51% | $19.97 (+28.09%) |
Apr 29, 2026 25w ago | DEFA14A | $12.28 $20.41 | ▲ +66.21% | ▲ +62.09% | $19.97 (+62.62%) |
Apr 27, 2026 26w ago | 8-K | $13.53 $20.31 | ▲ +50.11% | ▲ +45.33% | $19.97 (+47.60%) |
Showing 10 of 10
US Market Status
Market Open — Closes in 56m
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers